Updates are available Correction dated 2021-02-19
Click to view Correction: https://doi.org/10.1038/s41418-021-00748-5
-
Authors
Nelson, Victoria L.
Brunt, Keith R. http://orcid.org/0000-0002-5728-8135
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 6 November 2020
Accepted: 9 November 2020
First Online: 28 January 2021
Change Date: 19 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41418-021-00748-5
Compliance with ethical standards
:
: KRB holds a direct financial and equity interest in NBBM Inc. & ProtoKinetix Inc. directly related to regenerative medicine therapeutics development.
